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ttp://dx.doi.org/10.1016/j.ajpath.2013.09.021Hepatic cystogenesis in polycystic liver diseases is associated with abnormalities of cholangiocyte cilia.
Given the crucial association between cilia and centrosomes, we tested the hypothesis that centrosomal
defects occur in cystic cholangiocytes of rodents (Pkd2WS25/ mice and PCK rats) and of patients with
polycystic liver diseases, contributing to disturbed ciliogenesis and cyst formation. We examined
centrosomal cytoarchitecture in control and cystic cholangiocytes, the effects of centrosomal abnor-
malities on ciliogenesis, and the role of the cell-cycle regulator Cdc25A in centrosomal defects by
depleting cholangiocytes of Cdc25A in vitro and in vivo and evaluating centrosome morphology,
cell-cycle progression, proliferation, ciliogenesis, and cystogenesis. The cystic cholangiocytes had
atypical centrosome positioning, supernumerary centrosomes, multipolar spindles, and extra cilia.
Structurally aberrant cilia were present in cystic cholangiocytes during ciliogenesis. Depletion of
Cdc25A resulted in i) a decreased number of centrosomes and multiciliated cholangiocytes, ii) an
increased fraction of ciliated cholangiocytes with longer cilia, iii) a decreased proportion of chol-
angiocytes in G1/G0 and S phases of the cell cycle, iv) decreased cell proliferation, and v) reduced cyst
growth in vitro and in vivo. Our data support the hypothesis that centrosomal abnormalities in chol-
angiocytes are associated with aberrant ciliogenesis and that accelerated cystogenesis is likely due to
overexpression of Cdc25A, providing additional evidence that pharmacological targeting of Cdc25A has
therapeutic potential in polycystic liver diseases. (Am J Pathol 2014, 184: 110e121; http://dx.doi.org/
10.1016/j.ajpath.2013.09.021)Supported by the NIH (grants R01-DK24031 to N.F.L., P30-DK084567
to the Clinical Core and Optical Microscopy Core of the Mayo Clinic
Center for Cell Signaling in Gastroenterology, and P30-DK090728 to the
Mayo Translational Polycystic Kidney Disease Center), the Spanish
Ministry of Economy and Competitiveness (grant FIS PI12/00380 to
J.M.B.), the Department of Industry of the Basque Country (grant
SAIO12-PE12BN002 to J.M.B.), and the National Disease Research
Interchange (NDRI).
T.V.M. and S.-O.L. contributed equally to this work.Polycystic liver diseases (PLDs) are inherited genetic
disorders that include but are not limited to i) autosomal
dominant polycystic kidney disease (ADPKD), the most
common of these disorders; ii) autosomal recessive PKD
(ARPKD), less common but generally more severe; and
iii) autosomal dominant polycystic liver disease
(ADPLD), a rare condition in which cyst formation is
limited to the liver (unlike the other two conditions, in
which cysts occur in both liver and kidneys).1e4 Defects
in ciliary morphology and impaired ciliary-mediated
intracellular signaling trigger atypical cell cycle and
benign cell hyperproliferation, which are the major con-
tributors to cyst formation and expansion. Indeed, we andstigative Pathology.
.others have shown that abnormalities in ciliary length
(both elongation and shortening) and disturbed expression
of ciliary-associated proteins are sufﬁcient to generate the
pathological cystic phenotype.5e11
Centrosomal Abnormalities and Cdc25APrimary cilia have an intimate relationship with another
cell organelle, the centrosome. Centrosomes play an
important role in microtubule nucleation and organization,
in cell-cycle progression, migration, ubiquitin-proteasome
degradation, cell polarity and, importantly, in cilia forma-
tion.12,13 Centrosomes are composed of two centrioles
linked by interconnecting ﬁbers and surrounded by peri-
centriolar material. The older centriole (the mother
centriole) is structurally distinguished from the daughter
centriole by the presence of ﬁbrous appendages. In the G1/
G0 phase of the cell cycle, after centriole duplication, the
mother centriole is recruited to the apical cell membrane to
become the basal body, providing a template for nucleation
of the ciliary axoneme.13e17
Both ciliary and centrosomal defects have been detected
in nearly all human cancers. Many molecules have been
implicated in centrosomal abnormalities, but most experi-
mental evidence deﬁnes the tumor suppressor p53 (levels
of which are abnormal in most tumors) as a major regulator
of centrosome number, size, and appearance in can-
cer.13,14,18e23 Dysfunctional links between centrosomes
and primary cilia have also been observed in polycystic
kidney. Indeed, in several animal models of PKD and in
patients with ADPKD, renal epithelial and endothelial cells
have supernumerary centrosomes, defects in mitotic spin-
dle formation, abnormal cell division, and malformed
primary cilia.24e29
Our research group previously showed that primary cilia
in cholangiocytes lining liver cysts of animal models of
PLD (PCK rat and Pkd2WS25/ and Pkhd1del2/del2 mice) are
morphologically abnormal.7,30,31 However, the structural
and functional relationships between the centrosome and
primary cilia in cystic cholangiocytes have not been
addressed previously. Thus, to test the hypothesis that
centrosomal defects contribute to ciliogenesis and cyst
formation, we analyzed i) the centrosome cytoarchitecture
(ie, their number, size, and cellular position), ii) the
ability of supernumerary centrosomes to nucleate extra
cilia, iii) the effects of centrosomal abnormalities on
temporal ciliary growth (ie, ciliogenesis), and iv) the
potential mechanisms responsible for centrosomal aber-
rations in PLD. Our results show that i) cystic chol-
angiocytes of animal models and human patients with
PLD have improper centrosome positioning, over-
duplicated centrosomes, multipolar spindles, and extra
cilia; ii) these defects are associated with impaired cilio-
genesis in cystic cholangiocytes; iii) Cdc25A, a cell-cycle
phosphatase overexpressed in PLD,8 is involved in
regulation of the observed centrosomal abnormalities; and
iv) genetic and pharmacological suppression of Cdc25A
reduces the abnormal number of centrosomes per cell,
reduces the proportion of cholangiocytes with multiple
centrosomes and extra cilia, and alters the cell cycle,
leading to decreased cholangiocyte proliferation and
attenuated cyst growth. Taken together, our data conﬁrm
the importance of centrosomal abnormalities in hepaticThe American Journal of Pathology - ajp.amjpathol.orgcystogenesis and provide further support for Cdc25A as a
potential therapeutic target in PLD.
Materials and Methods
Animals and Cell Cultures
Animals were maintained on a standard diet and water ad
libitum. After anesthesia (50 mg/kg pentobarbital) and sac-
riﬁce, liver and kidney were parafﬁn-embedded for histology
studies. Cholangiocytes were isolated from control and PCK
rats as described previously.32 PCK cholangiocytes were
stably transfected with Cdc25A shRNA (PCK-Cdc25A-sh)
or empty vector (PCK-Cdc25A-EV) using forward and
reverse primers 50-TAGCAGCAGTCTACAAGAGAAT-30
and 50-GGAATCTCATTCGATGCATAC-30) (Qiagen,
Valencia, CA). PCK cholangiocytes stably transfected with
miR-15a precursor (PCK-miR-15a-pre) or miR empty vector
(PCK-miR-EV) were previously established by our research
group.33 The protocol was approved by the Mayo Institu-
tional Animal Care and Use Committee.
Electron Microscopy
For scanning electron microscopy (SEM), samples were
incubated in 1% osmium tetroxide for 30 minutes, dehydrated,
dried in a critical-point drying device, mounted onto specimen
stubs, and sputter-coated with goldepalladium alloy. SEM
micrographs were used with ImageJ software version 1.46
(NIH, Bethesda, MD) to analyze ciliary position and ciliary
length. SEM was performed with a Hitachi S-4700 electron
microscope (Hitachi High Technologies America, Pleasanton,
CA). For transmission electron microscopy (TEM), samples
were ﬁxed in 1% osmium tetroxide for 1 hour, rinsed in
distilled water, dehydrated, embedded in Spurr’s resin, and
sectioned at 80 nm. TEM was performed with a JEOL 1200
electron microscope (JEOL USA, Peabody, MA). TEM mi-
crographs were used with ImageJ software to measure dis-
tances between basal bodies and cell lateral junctions,
distances between centrioles, and length of the basal bodies.
Immunoﬂuorescence Confocal Microscopy
Confocal microscopy was performed with a Zeiss LSM-510
microscope (Carl Zeiss, Thornwood, NY) using liver tissue of
control and PCK rats; of control, Pkd2WS25/, Pkhd1del2/del2,
Cdc25Aþ/, and Pkhd1del2/del2:Cdc25Aþ/ mice; and of
healthy human subjects and patients with ADPKD and
ARPKD. Normal and diseased human liver tissues were ob-
tained from the Mayo Clinical Core facility and National
Disease Research Interchange. Liver sections were stained
with primary antibodies against g-tubulin (1:100; Sigma-
Aldrich, St Louis, MO), acetylated a-tubulin (1:100; Sigma-
Aldrich); pericentrin (1:100; Abcam, Cambridge, MA); p53
(1:50; Santa Cruz Biotechnology, Santa Cruz, CA); p21 (1:50;
Abcam), Cdk2 (1:100; BD Biosciences, San Jose, CA), cyclin111
Figure 1 Cystic cholangiocytes possess multiple
centrosomes and multipolar spindles. A and B: Greater
numbers of PCK cholangiocytes with multiple centro-
somes (A) and numerous mitotic spindles (B) were
observed in vitro. C: The number of centrosomes per
cell and the percentage of cholangiocytes with extra
centrosomes are increased in liver cysts of rodents and
patients with polycystic liver diseases. Centrosomes
(green) and mitotic spindles (red) were stained with
g-tubulin; nuclei were counterstained with DAPI
(blue). Data are expressed as means  SEM. n Z 100
cholangiocytes per condition. *P < 0.05 versus con-
trol. Original magniﬁcation, 100. L, lumen.
Masyuk et alE (1:100; Santa Cruz Biotechnology), and Cdc25A (1:100;
Santa Cruz Biotechnology). The respective secondary anti-
bodies (1:100) were applied. Nuclei were counterstained with
DAPI (Life Technologies, Carlsbad, CA).
Western Blotting
We used 4% to 15% SDS-PAGE to separate proteins, which
then were transferred to nitrocellulose membranes (Bio-Rad
Laboratories, Hercules, CA) and probed with antibodies
against p53, p21, Cdk2, cyclin E, and Cdc25A overnight at
4C. Actin staining was used for normalization of protein
loading. Membranes were washed and incubated for 1 hour at
room temperature with corresponding horseradish perox-
idaseeconjugated (Life Technologies) or Odyssey IRdye 680
or 800 (LI-COR, Lincoln, NE) secondary antibodies. Bands
were visualized with an ECL Plus Western blotting detection
kit (BD Biosciences) or an Odyssey Li-Cor scanner.
Flow Cytometry
PCK-Cdc25A-sh, PCK-Cdc25A-EV, PCK-miR-15a-pre,
and PCK-miR-EV (nZ 5 for each cell line) cholangiocytes112were ﬁxed in ethanol and suspended in 50 mg/mL propidium
iodide containing 0.1 mg/mL RNase. Cell-cycle analysis
was performed at the Mayo Advanced Genomics Technol-
ogy Center.
Cell Proliferation Assay
PCK-Cdc25A-sh, PCK-Cdc25A-EV, PCK-miR-15a-pre, and
PCK-miR-EV (nZ 8 for each cell line) cholangiocytes were
grown at 37C, 5% CO2, and 100% humidity for 72 hours
before the assay. The proliferation rate was determined using a
CellTiter 96 Aqueous One Solution cell proliferation assay
(Promega, Madison, WI) and a bromodeoxyuridine cell pro-
liferation assay (Cell Signaling Technology, Danvers, MA).
Three-Dimensional Cultures and Cyst Measurement
PCK-Cdc25A-sh and PCK-Cdc25A-EV cholangiocytes were
grown in three-dimensional matrices, as described previ-
ously.33 Cyst expansion was evaluated by light microscopy at
days 1 (ie, 24 hours after seeding), 2, and 3. The circumferential
area of each cyst (n Z 50 for each condition) was measured
using ImageJ software, as described previously.8ajp.amjpathol.org - The American Journal of Pathology
Figure 2 Cystic cholangiocytes are multiciliated. A and B: Numbers of cilia per cell assessed by confocal microscopy (A) and SEM (B) were increased in PCK
cholangiocytes. Arrows in B indicate cilia. C: Confocal micrographs conﬁrmed that primary cilium (green) arises from the basal bodies (red). D: Cholangiocytes
with extra cilia are present in liver cysts of rodents and patients with polycystic liver diseases. E: Occurrence of multiciliated cholangiocytes was conﬁrmed by
SEM. Note that cilia in cystic cholangiocytes are shorter and malformed. Cilia were stained with a-tubulin [red (A and D) or green (B)] and basal bodies with g-
tubulin (red); nuclei were counterstained with DAPI (blue). Cilia are indicated by arrows (B). Data are expressed as means  SEM. nZ 75 cholangiocytes per
condition. Original magniﬁcation, 100. Scale bars: 5 mm (B); 1 mm (E). L, lumen.
Centrosomal Abnormalities and Cdc25AStatistical Analysis
GraphPad Prism software version 4.0 (GraphPad Software,
San Diego, CA) was used for statistical analysis. Statistical
signiﬁcance between two groups was tested by Student’s
t-test. Data are expressed as means  SEM, and differences
of P < 0.05 were considered signiﬁcant.
Results
Cystic Cholangiocytes Are Characterized by the
Presence of Supernumerary Centrosomes
In cultured cystic cholangiocytes, we observed three to ﬁve
centrosomes per cell and an increase to 15% in the quantity
of cells with multiple centrosomes, compared with control
(Figure 1A). The fraction of cholangiocytes with tripolarThe American Journal of Pathology - ajp.amjpathol.organd multipolar spindle formations was also approximately
two times greater (Figure 1B). Consistent with the in vitro
observations, an approximate twofold increase in the per-
centage of cholangiocytes with multiple centrosomes was
found in liver cysts of the PCK rat and Pkd2WS25/ mouse,
compared with controls, as well as in patients with PLD
(Figure 1C).Supernumerary Centrosomes in Cystic Cholangiocytes
Nucleate Extra Cilia
We investigated whether the additional centrosomes might
produce extra cilia. Unlike controls, up to 8% of cystic
cholangiocytes in vitro (Figure 2, AeC) and up to 6% of
cystic cholangiocytes in vivo (Figures 2D and 3) were
multiciliated, containing two or more cilia per cell.113
Figure 3 Centrosomal abnormalities in cystic
cholangiocytes. A: Representative micrographs
and graph showing the distance from the basal
body (arrows) to the daughter centriole. B: In PCK
rats, centrioles are longer, with electrodense spots
(asterisks) and extra appendages (arrows). C:
Basal bodies (arrows) in cystic cholangiocytes are
positioned closer to the cell center. The diagram
summarizes the basal body position relative to the
cell lateral junction (L). D: SEM images and sche-
matic diagrams illustrate the position of primary
cilium. Cell center (black circle) was identiﬁed as
the intersect of longest (L1e2, dashed line) and
shortest (S1e2, solid line) cell axis. Position of
cilia was measured along both axes. In cystic
cholangiocytes, cilia are found closer to the cell
center, compared with controls (P Z 0.03).
Cholangiocytes marked with an asterisk are shown
in greater detail in the corresponding inset. Data
are expressed as means  SEM. n Z 50 chol-
angiocytes for each condition. *P < 0.05. Original
magniﬁcation, 2000 (D). Scale bars: 500 nm (A
and B); 1 mm (C).
Masyuk et alCentrosomes of Cystic Cholangiocytes Exhibit an
Aberrant Phenotype
We further analyzed centrosomal defects (cellular position,
length, and presence of extra appendages). In control chol-
angiocytes, the daughter centriole was positioned close to a
mother centriole (basal body), but in cystic cholangiocytes
this distance was increased (Figure 3A). Basal bodies were
approximately 30% longer in cystic cholangiocytes and
contained electrodense material and extra appendages
(Figure 3B). In control cholangiocytes, the basal body was
positioned close to one of the lateral junctions, whereas in
cystic cholangiocytes it was located closer to the cell center
(Figure 3C). Consistent with the more central location of the
basal body, the primary cilium in PCK cholangiocytes was114also situated nearer the cell center (Figure 3D). Finally,
basolaterally located centrioles were observed in chol-
angiocytes lining hepatic cysts in rodent models and in
patients with PLD, whereas in the respective controls the
centrioles were adjacent to the apical membrane (Figure 4).
Ciliogenesis Is Impaired in Cystic Cholangiocytes
Ciliogenesis was examined in cholangiocytes derived from
control and PCK rats (Figure 5). Cilia were not present in
subconﬂuent (day “”0) and immediately postconﬂuent
(day 0) cholangiocytes. Cilia ﬁrst appeared at day 3 after
conﬂuence and continued to grow, reaching a maximum
size of approximately 10 to 12 mm by day 10 to 12. At all
time points, cilia of PCK cholangiocytes were shorter byajp.amjpathol.org - The American Journal of Pathology
Figure 4 Centrosomal abnormalities in cystic cholangiocytes. Basolat-
erally located centrosomes (asterisks) are revealed in cystic cholangiocytes
by confocal microscopy. Presence of basolaterally located centrosomes was
conﬁrmed in PCK rats by TEM. The boxed region is shown in greater detail
in the inset. Centrioles are stained with g-tubulin (green) or pericentrin
(red). Nuclei are counterstained with DAPI (blue). Images are representa-
tive of 50 cholangiocytes for each condition. Original magniﬁcation, 100.
Scale bar Z 2 mm. L, lumen.
Figure 5 Ciliogenesis is impaired in PCK cholangiocytes. Cilia were
detected by SEM (left and middle columns) and confocal microscopy
(right column) over time. Cilia were stained with a-tubulin (green); nuclei
were counterstained with DAPI (blue). Images are representative of chol-
angiocytes for each time point and experimental condition. Original
magniﬁcation, 100 (right column). Scale bars: 5 mm (left column); 1
mm (middle column).
Centrosomal Abnormalities and Cdc25Aapproximately 30% (P < 0.05). In addition, approximately
9% of PCK cholangiocytes were multiciliated, with two or
three cilia per cell.
Expression of Proteins Involved in Centrosomal
Abnormalities in Cystic Cholangiocytes Is Up-
Regulated
The overduplication of centrosomes and their abnormal
morphological appearance in cancer is controlled by the
p53ep21eCdk2ecyclin E axis. We therefore examined the
expression of these proteins in benign hyperproliferative
cystic cholangiocytes. No changes in p53 and p21 levels
were observed, whereas their downstream effectors, Cdk2
and cyclin E, were up-regulated (Figure 6). Consistent with
our previous data,33 expression of the phosphatase Cdc25A,
which activates the Cdk2ecyclin E complex during the cell-
cycle transition, was also increased (Figure 6).
Cdc25A Plays an Important Role in Centrosomal
Abnormalities
To address the role of Cdc25A in maintenance of centrosome
architecture, we modiﬁed PCK cholangiocytes by depleting
Cdc25A with speciﬁc shRNA (PCK-Cdc25A-sh). We alsoThe American Journal of Pathology - ajp.amjpathol.orgused PCK cholangiocytes transfected with an miR-15a pre-
cursor (PCK-miR-15a-pre) previously established in our
laboratory.33 Cdc25A up-regulation in cystic cholangiocytes
is a result of miR-15a inhibition, because treatment of PCK
cholangiocytes with miR-15a precursor increases miR-15a,
subsequently decreasing Cdc25A expression.33
Western blotting demonstrated that both approaches reduced
protein levels of Cdc25A (Figure 7A), leading to a decreased
proportion of cholangiocytes in S phase (PCK-Cdc25A-sh) and115
Figure 6 Expression of proteins involved in centrosomal abnormalities. A: Western blots (nZ 3) show that levels of p53 and p21 are not affected in cystic
cholangiocytes, but expression of Cdk2 and cyclin E is increased. Cdc25A phosphatase, the upstream activator of the Cdk2ecyclin E complex, is also up-
regulated. B: Overexpression of Cdk2, cyclin E, and Cdc25A was conﬁrmed by confocal microscopy in cholangiocytes of rodents and patients with polycy-
stic liver diseases. Proteins of interest stain green; nuclei stain blue. Features marked by an asterisk are shown without nuclear staining in the corresponding
inset. Data are expressed as means  SEM. *P < 0.05. Original magniﬁcation, 63. C, control.
Masyuk et alin G1/G0 phase (PCK-miR-15a-pre) (Figure 7B) of the cell
cycle, reduced cell proliferation (Figure 7C), and decrease in
centrosome number per cell and the percentage of cells with
multiple centrosomes (Figure 8A). In addition, the number of
mitotic spindles per cell and the fraction of PCK cholangiocytes
with multiple spindles was reduced by 25% (P < 0.05),
compared with respective controls. Ciliogenesis was also
affected in response to Cdc25A depletion. The number of
ciliated PCK-Cdc25A-sh cholangiocytes was increased to
63.17  6.98%, compared with 44.72  7.42% in PCK-116Cdc25A-EV (P < 0.05) (Figure 8B), and cilia were longer
(4.82 0.43 mm) than in control (3.36 0.48 mm) (P< 0.05).
Similar effects were observed in PCK-miR-15a-pre chol-
angiocytes (data not shown). Finally, the growth rate of cysts
formed in three-dimensional cultures by miR-15a-pre chol-
angiocytes (Figure 8C) or PCK-Cdc25A-sh cholangiocytes
(data not shown) was decreased, compared with control.
To conﬁrm the role of Cdc25A in centrosomal abnormal-
ities in vivo, we used Cdc25Aþ/:Pkhd1del2/del2 cross-bred
mice, as recently established in our laboratory; these miceajp.amjpathol.org - The American Journal of Pathology
Figure 7 A: Depletion of Cdc25A by shRNA or by miR-15a precursor reduces Cdc25A levels in cystic cholangiocytes, as assessed by Western blotting. B and
C: These perturbations affect cell cycle (B) and inhibit cell proliferation (C). Data are expressed as means  SEM. nZ 3. *P < 0.05. BrdU, bromodeoxyuridine;
EV, empty vector.
Centrosomal Abnormalities and Cdc25Ahave reduced expression of Cdc25A and decreased cystic
areas, compared with Pkhd1del2/del2 mice (an animal model of
PLD characterized by elevated Cdc25A levels and severe
cystogenesis).8 In Cdc25Aþ/:Pkhd1del2/del2 mice, compared
with Pkhd1del2/del2 mice, we observed a 25% reduction of
centrosomes per cell by number and a 35% reduction in
fraction of cystic cholangiocytes with multiple centrosomes
(Figure 9A). We also observed a decreased number of cilia per
cell and a decreased percentage ofmulticiliated cholangiocytes
(Figure 9B), as well as increased (by 36.7%) length of cilia
(P < 0.05). In Cdc25Aþ/:Pkhd1del2/del2 mice, more centro-
somes (75.8%) were positioned closer to apical surface,
compared with 39.7% in Pkhd1del2/del2 mice (P < 0.05).
Moreover, consistent with previous report,8 cystic areas in
Cdc25Aþ/:Pkhd1del2/del2 mice were reduced to 28.35 
4.56%, compared with 44.96  6.39% in Pkhd1del2/del2 mice
(P< 0.05). These data show that depletion of Cdc25A levels in
vivo can reverse the structural ciliary and centrosomal abnor-
malities seen in animalmodels of PLD (ie,Pkhd1del2/del2mice).
Discussion
We made the following ﬁndings in cystic cholangiocytes: i)
numerous centrosomes, multipolar spindles and extra cilia
are present; ii) the distance between mother and daughter
centrioles is increased; iii) centrosomes have extraThe American Journal of Pathology - ajp.amjpathol.orgappendages and electrodense spots; iv) both centrosomes and
primary cilia are improperly positioned; v) ciliogenesis is
impaired, with reduced numbers of ciliated cells and with
shorter cilia; vi) expression of Cdc25A and its downstream
effectors that control centrosome duplication, Cdk2 and
cyclin E, are up-regulated; vii) depletion of Cdc25A in vitro
by molecular manipulations affects the cell cycle, decreases
cell proliferation and the number of cells with multiple cen-
trioles, improves ciliogenesis, and reduces growth of cystic
structures in three-dimensional cultures; and viii) depletion of
Cdc25A in vivo by genetic manipulation decreases the frac-
tion of cholangiocytes with improperly positioned centrioles,
supernumerary centrosomes, and extra cilia and subsequently
attenuates hepatic cystogenesis. These data support the hy-
pothesis that, in a benign hyperproliferative condition such as
PLD, centrosomal abnormalities contribute to deregulation of
ciliogenesis and cystogenesis and that the overexpression of
Cdc25A plays an important role in this phenomenon.
The number of centrosomes is strictly controlled during
the cell cycle. Disruption of centrosome duplication leads to
centrosomal overampliﬁcation, atypical cytoarchitectural
positioning, structural defects, formation of spindles with
multiple poles, and aberrant ciliogenesis. Numerous cen-
trosomal abnormalities have been described in cancer, and
more recently also in kidney in animal models of PKD and
also in humans with PKD.14,20,21,23,24,29,34117
Figure 8 A: Depletion of Cdc25A by shRNA or by miR-15a precursor decrease number of centrosome per cell and fraction of cholangiocytes with multiple
centrosomes. B: Ciliogenesis was examined by confocal microscopy in PCK-Cdc25A-sh cholangiocytes. C: Cyst growth was evaluated by light microscopy in PCK-
miR-15a-pre cholangiocytes. Centrosomes were stained with g-tubulin (green) and cilia with a-tubulin (red); nuclei were counterstained with DAPI (blue).
Data are expressed as means  SEM. nZ 50 cholangiocytes (A and B) and nZ 25 cysts (C) for each condition. *P < 0.05. Original magniﬁcation: 100 (A
and B); 4 (C). EV, empty vector.
Masyuk et alHere, we have reported for the ﬁrst time that centrosome
defects occur in cystic cholangiocytes of animal models and
in humans affected by cystic liver diseases and have pro-
vided novel information on the mechanisms underlying
these phenomena.
The potential consequences of centrosome hyper-
ampliﬁcation might include nucleation of extra cilia and
impaired ciliogenesis.11,20,23 Indeed, the number of multi-
ciliated cystic cholangiocytes was increased in PLD. Chol-
angiocytes with overduplicated centrosomes and extra cilia
represent a relatively small fraction, but a signiﬁcant frac-
tion compared with control. This reﬂects the nature of cyst
formation as a slow-progressive event that involves a rather
low number of bile ducts. It might also reﬂect the fact that
cystic tissue comprises heterogeneous cell populations (ie,118with both multiple and normal centrosome numbers), as is
seen in cancer tissue.20
To assess the role of centrosomal cytoarchitectural defects
in ciliogenesis, we isolated cholangiocytes from control and
PCK rats and examined the growth of cilia over the course of
21 days. The PCK cholangiocytes had aberrant ciliogenesis;
the number of ciliated cells was decreased, compared with
control, and the cilia were shorter. Current evidence suggests
that ciliary length is important for normal cell functioning and
is relatively consistent within a cell type.17,35 We and others
have shown that hepatic and renal cystogenesis in PKD is
associated with either excessively long or short cilia.7,10,17,30
Our present ﬁndings suggest that ciliary growth is affected by
centrosomal abnormalities. Subsequently, atypical cilia might
not provide proper signaling into the cell interior to inﬂuenceajp.amjpathol.org - The American Journal of Pathology
Figure 9 Effects of Cdc25A depletion on centrosomal and ciliary abnormalities in vivo. A and B: Confocal and light microscopy reveals the presence of
centrosomes (g-tubulin stain, green) (A) and ciliated cells (a-tubulin stain, red) (B) in bile ducts of C mice (Cdc25Aþ/), P mice (Pkhd1del2/del2), and C:P mice
(Pkhd1del2/del2:Cdc25Aþ/). Nuclei are counterstained with DAPI (blue). Basolaterally positioned centrioles are indicated by small white asterisks. An enlarged
view of a cholangiocyte (arrow) with extra cilia is shown in the inset. Data are expressed as means  SEM. nZ 3 (C mice and C:P mice); nZ 4 (P mice). *P <
0.05. Original magniﬁcation, 100. L, bile duct or cyst lumen.
Centrosomal Abnormalities and Cdc25Acell-cycle progression and precise centrosome duplication
and/or positioning.
Primary cilia in any tubular epithelia are situated on the
apical membrane; however, the positioning with respect to
the cell center might vary depending on the cell type.36
Proper ciliary positioning is crucial for their optimal func-
tioning, and incorrect ciliary localization is a hallmark of
many ciliopathies.20,23,36 Our ﬁnding that the position of the
basal body is atypical in cystic cholangiocyte is consistent
with an abnormal cellular location of the cholangiocyte
cilium; both centrosomes and cilia were found closer to the
cell center than in control cells. In cystic cholangiocytes (but
not in controls), centrosomes were also observed inCdc25A
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The American Journal of Pathology - ajp.amjpathol.orgbasolateral membrane region. In accord with the present
ﬁndings, centrosomes were reported to be improperly
positioned in kidneys of a mouse model of PKD.37
The precise mechanisms responsible for centrosome
ampliﬁcation remain unclear. Centrosome duplication is
initiated in the G1eS phase of the cell cycle and requires the
coordinated functioning of the Cdk2ecyclin E complex, the
activity of which is controlled by p53 and p21waf1/Cip1 and
Cdc25A phosphatase.12,14,20,21,23 Although experimental
evidence suggests that in many cancers centrosomal ab-
normalities are p53/p21edependent,20,38 these defects have
been also described in the absence of p53 deregulation.22,34
Indeed, levels of p53 and p21 were unchanged in cysticystic 
ngiocytes
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Figure 10 Overexpression of Cdc25A in cystic
cholangiocytes triggers centrosome defects,
improper ciliogenesis, and cyst growth. Depletion
of Cdc25A by different approaches affects
centrosome cytoarchitecture, improves cilio-
genesis, and decreases hepatic cystogenesis.
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Masyuk et alcholangiocytes, whereas expression of their downstream
target, Cdk2ecyclin E, was elevated. The fact that cysto-
genesis is a benign hyperproliferative condition (as opposed
to malignant cell growth) is potentially consistent with these
differences.
Our research group recently showed that the cell-cycle
phosphatase Cdc25A (the upstream regulator of Cdk2ecyclin
E) plays an important role in hepatic cystogenesis, and its
targeting by either pharmacological or genetic manipulations
reduces cyst growth in animal models of PLD.8 Furthermore,
levels of Cdk2 and cyclin E are signiﬁcantly reduced in
response to Cdc25A inhibition.8 Finally, Cdc25A over-
expression in cystic cholangiocytes is the result of the down-
regulation of miR-15a, a miRNA with complementarity to
Cdc25A mRNA.33 In the present study, to assess whether
Cdc25A contributed to the centrosomal abnormalities in cystic
cholangiocytes, we used three different approaches to deplete
Cdc25A levels: Cdc25A shRNA and a miR-15a precursor
in vitro and genetic manipulation through cross-breeding
in vivo. Under experimental conditions of Cdc25A inhibi-
tion, virtually all of the centrosome and ciliary abnormalities in
cystic cholangiocytes (ie, the number of centrioles per cell and
the portion of multiciliated cholangiocytes and fraction of cells
with improper ciliary positioning) were abrogated, reducing
both proliferation and cyst growth. A working model for these
phenomena is presented in Figure 10. Moreover, we had
previously shown that suppression of miR-15a in control
cholangiocytes up-regulates Cdc25A levels, subsequently
increasing cell proliferation and cyst growth.33 Thus, taken
together, our data suggest that Cdc25A is involved in main-
tenance of centrosome cytoarchitecture.
Although it has been shown that centrosomal abnormal-
ities in cancer correlate with cell aneuploidy, recent evidence
suggests that cells may retain the diploid karyotype even in
the presence of excessive centrosomes.14,20,22 Indeed, cystic
cholangiocytes are diploid.8 Moreover, aneuploidy in cancer
occurs via a p53-dependent mechanism, but we detected no
changes in p53 levels in cystic cholangiocytes. These ﬁnd-
ings further indicate that centrosomal abnormalities in a
benign hyperproliferative disease such as PLD are linked to
different intracellular pathways than in cancer.
In conclusion, we observed multiple centrosomal
cytoarchitectural defects in cystic cholangiocytes. These
were associated with multiciliated cholangiocytes, delayed
ciliogenesis, and shortened cilia. Our data suggest that up-
regulation of the cell-cycle phosphatase Cdc25A contributes
to these events. The data further suggest that therapeutic
interventions targeting Cdc25A might be of signiﬁcant
beneﬁt in the treatment of PLD.
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